A Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/ Refractory Plasma Cell Leukemia

NCT06730256 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Relapsed/Refractory Plasma Cell Leukemia
Relapsed/Refractory Multiple Myeloma

Interventions

DRUG: CAR-T cells Infusion chimeric antigen receptor T cells

Sponsor

The First Affiliated Hospital of Soochow University

Collaborators

[object Object]